Synevo Bulgaria

What Synevo Bulgaria does

Synevo Bulgaria (СМДЛ Синево България ЕООД) is a medical laboratory diagnostics operator and a subsidiary of the Stockholm-listed Medicover Group, which has operated in European healthcare for more than 25 years. The company operates a national network of more than 70 patient collection points across 14 Bulgarian cities and offers a catalogue of over 3,000 diagnostic tests spanning routine clinical chemistry, immunology, microbiology, genetic and hereditary panels (ADVENTIA carrier screening, PreSENTIA hereditary cancer testing), non-invasive prenatal testing (VERACITY / VERAgene), specialty assays (BORRELIA LTT), and packaged screening programs for conditions such as thyroid disorders and diabetes.

The business operates a multi-channel revenue model. It serves as a contracted provider under Bulgaria's National Health Insurance Fund (NHIF) for reimbursed testing, accepts voluntary health insurance, and sells directly to self-pay patients through its network and an online ordering channel with an introductory 10% discount. Patient results are delivered through the SynevoWeb platform, and the company has announced online payment integration via myPOS for 2026 alongside additional collection point openings in Sofia.

The company is structured as a Bulgarian private limited liability company (ЕООД) with a listed headcount of 52 employees, likely reflecting core corporate and laboratory staff given the broader network of collection points. As part of the international Synevo network under Medicover, the entity benefits from shared protocols, procurement, and quality benchmarks across multiple European markets, while executing its growth strategy within Bulgaria through geographic densification, test menu expansion into higher-value specialty and genetic testing, and digitization of the patient-facing experience.

Name

Synevo Bulgaria

Legal name

СМДЛ Синево България ЕООД

Website

https://synevo.bg

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Synevo Bulgaria is a medical laboratory diagnostics operator and Medicover subsidiary running 70+ collection points across 14 Bulgarian cities, offering 3,000+ tests to NHIF-reimbursed, insured, and self-pay patients.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

akta.pro secondary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

Keywords

• Medical laboratory diagnostics
• Genetic testing services
• Prenatal screening tests
• Preventive health screening
• Clinical blood analysis

Headquarters

HQ city

Sofia

HQ country

Bulgaria

HQ region

Europe

Offices14 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Diagnostic Services: Core revenue from providing medical laboratory diagnostic tests across 3000+ offerings including routine blood tests, specialized genetic tests, prenatal screening, tumor markers, and more. Revenue generated through a combination of National Health Insurance Fund (НЗОК) reimbursements for insured patients, voluntary health insurance fund payments, and direct patient self-pay.
2. Online Ordering Platform: Online test ordering service where patients pre-register tests through the website, receiving a 10% discount on most tests. Includes biological material fee of approximately 2.00 EUR. Platform also supports gifting of health tests to others.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels10 records

Core offering

Synevo Bulgaria is a private medical laboratory network offering more than 3,000 routine and specialized diagnostic tests through 70+ collection points across 14 Bulgarian cities. Core offerings include routine blood and biochemistry, hormonal and immunological assays, microbiological cultures, allergy testing, specialized genetic panels (ADVENTIA carrier screening, PreSENTIA hereditary cancer), non-invasive prenatal testing (VERACITY, VERAGENE), BORRELIA LTT for Lyme disease, and disease-specific screening packages for thyroid, diabetes, pregnancy, and preventive health. Services are delivered through physical sample collection, an online ordering platform with 10% discount, and the SynevoWeb digital results portal, with payment covered by self-pay, НЗОК referrals, or voluntary health insurance.

Product overview

Synevo Bulgaria is a medical diagnostic laboratory network operating under the Medicover international healthcare organization. The company offers a unified platform of laboratory diagnostic services supplemented by digital patient-facing tools. Its core portfolio spans over 3000 routine and specialized diagnostic tests organized into product lines including: the ADVENTIA genetic carrier screening family (Basic panel with 22 genes, Specialized panels for cystic fibrosis and other conditions, and Expanded panel with 231 genes); the PreSENTIA hereditary cancer testing suite (19 panels covering breast/gynecological, colorectal, pancreatic, prostate, kidney, thyroid, melanoma, and pan-cancer); VERACITY and VERAGENE non-invasive prenatal tests; thyroid, diabetes, and preventive health screening packages; and BORRELIA LTT for Lyme disease. These are complemented by digital services including SynevoWeb for online result access and an online ordering e-shop with 10% discount. The network spans 70 collection sites across Bulgaria, accepts NHIF (National Health Insurance Fund) referrals, and is supported by the international Synevo brand operating in multiple European countries.

Differentiator

Problem solved

Functional benefit

Brands

• PreSENTIA: Genetic test panels for hereditary cancer screening offering 19 cancer panels
• ADVENTIA
• VERACITY
• VERAgene
• SynevoWeb

Products and services

• ADVENTIA Carrier Screening Genetic Tests Genetic carrier screening panels offered to individuals and couples planning pregnancy, analyzing genes associated with hereditary conditions using next-generation sequencing and other targeted technologies. Panels include alpha-thalassemia, beta-thalassemia, cystic fibrosis, Fragile X syndrome, spinal muscular atrophy, and others.
• PreSENTIA Hereditary Cancer Panels Hereditary cancer genetic test panels offered to adults with family history or clinical indication for cancer predisposition assessment. Each panel tests multiple genes (e.g., BRCA1, BRCA2, Lynch syndrome genes, ATM, CHEK2, HOXB13) for germline mutations associated with specific cancer syndromes.
• VERACITY Non-Invasive Prenatal Test (NIPT) NIPT offered to expectant mothers for non-invasive screening of fetal chromosomal abnormalities using a single maternal blood draw.
• VERAGENE Non-Invasive Prenatal Test Combined NIPT + carrier screening prenatal test for expectant mothers seeking comprehensive fetal genetic assessment in a single workflow.
• SynevoWeb Online Results Platform Digital patient portal providing secure, anytime online access to Synevo laboratory test results and personal health records.
• Synevo Online Ordering (E-Shop)

Quantifiable outcome

• 70+ locations providing widespread access to laboratory services
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Medicover GroupcoreOthersSynevo Bulgaria is a wholly-owned subsidiary of Medicover, an international health organization operating in Europe for over 25 years. The Medicover Group provides the international standards, quality frameworks, and network resources that Synevo Bulgaria operates under. This parent relationship provides access to international best practices in laboratory diagnostics and genetic testing technologies.
• International Synevo NetworkcoreStrategic or Co-development PartnerSynevo Bulgaria is part of the international Synevo laboratory network spanning Germany (IMD Berlin), Romania, Ukraine, Serbia (Beo-Lab), Turkey, Moldova, Georgia, Cyprus (NIPD Genetics), and Finland (Medicover Genetics). This network enables knowledge sharing, best practice exchange, and potentially cross-border laboratory services.
• National Health Insurance Fund (НЗОК)coreChannel Partner/ Reseller/ DistributorSynevo Bulgaria operates as a contracted provider under the Bulgarian National Health Insurance Fund (Национална здравноосигурителна каса). This partnership allows insured Bulgarian citizens to access laboratory diagnostic services covered by the national health insurance scheme with valid doctor's referrals (направления).
• Voluntary Health Insurance FundsminorChannel Partner/ Reseller/ DistributorSynevo Bulgaria partners with voluntary (допълнително) health insurance funds in Bulgaria to provide laboratory diagnostic services covered under supplemental insurance policies. Patients with voluntary health insurance can access covered tests at Synevo locations.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Centogene: Centogene is a specialty genetic testing and biomarker company focused on rare diseases and hereditary diagnostics across Europe and the Middle East. It overlaps with Synevo Bulgaria's PreSENTIA hereditary cancer and ADVENTIA carrier screening franchises, particularly in cross-border specialty testing.
• NIPD Genetics: NIPD Genetics is a Cyprus-based genetic testing company, part of the broader Medicover/Synevo international network, specializing in non-invasive prenatal testing and reproductive genetics. It is both a sister entity and a direct product-line peer for Synevo Bulgaria's VERACITY/VERAgene NIPT franchise.

Direct peers

• Synlab: Synlab is the largest European medical diagnostic laboratory network, operating clinical labs and collection points across more than 30 countries. It directly competes with Synevo Bulgaria in routine and specialty diagnostics, with overlapping B2C and B2B testing menus and a similar collection-point model in Central and Eastern Europe.
• Cerba Healthcare: Cerba Healthcare is a European network of medical laboratories and specialty diagnostic providers (including Lifebrain), serving hospitals, clinicians, and patients across multiple European markets. It directly mirrors Synevo Bulgaria's mix of routine clinical labs plus specialty and genetic testing.
• Medicover (Synevo Network — Romania): Medicover's Romanian Synevo operation is the closest sibling to Synevo Bulgaria, sharing the same parent, brand, technology platform, and collection-point model. It serves as the most direct operational and strategic comparable for Synevo Bulgaria's network economics and product mix.
• Unilabs: Unilabs is a major European clinical laboratory and diagnostic services provider with extensive collection networks across Western, Northern, and parts of Eastern Europe. It competes head-to-head with Synevo Bulgaria in routine clinical chemistry, specialty testing, and genetic diagnostics, with comparable insured and self-pay models.

Others

• Eurofins Genomics: Eurofins Genomics is the genomics arm of Eurofins Scientific, offering DNA sequencing, genotyping, and specialty genetic services globally. While not a direct clinical lab competitor in Bulgaria, it represents an alternative supply and technology channel for advanced genetic testing services that compete with Synevo Bulgaria's specialty menu.

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is one of the world's largest clinical laboratory networks, offering routine and specialty testing including advanced genetics. Although US-based, it is a useful incumbent benchmark for scale, payer mix, and genetic test menu breadth relative to Synevo Bulgaria's specialty offering.
• Laboratory Corporation of America (Labcorp): Labcorp is a global clinical laboratory and diagnostics company with broad routine and specialty (including genetic) testing. It serves as a global incumbent comparable for Synevo Bulgaria's specialty and genetic testing strategy, even though it does not directly serve Bulgaria.
• Medicover (Parent Group): Medicover is the publicly listed Swedish parent of Synevo Bulgaria, operating healthcare and diagnostic services across more than a dozen European countries. While much larger and broader, the parent is the natural benchmark for Synevo Bulgaria's unit economics, brand, and capital allocation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubebit.ly/2Sne1gd
• Facebookfacebook.com/synevo.bulgaria
• LinkedInlinkedin.com/company/synevo-bulgaria
• Instagraminstagram.com/synevo_bulgaria
• TikToktiktok.com/@synevo_bulgaria

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synevo Bulgaria